BAFNA
Buying gold this Dhanteras: Gold price down by 18% from record high, can it recover to January peak next year?
Dhanteras Gold Price return: Gold rates have seen a sharp decline after scaling to a record high earlier this year, resulting in varied investment outcomes. With Dhanteras on the horizon, many buyers are hopeful for profits despite the market's fluctuations. Experts recommend a cautious approach, favouring staggered purchases over lump sum investments. Looking ahead, price predictions suggest that global economic factors will play a significant role in shaping future gold values, making it crucial for investors to stay informed.
Diwali 2026: 77 stocks knock down D-St bears to deliver multibagger returns of up to 4,700% in a year
With Diwali 2026 on the horizon, 77 stocks have thrived despite market fluctuations, marking exceptional returns. Mrugesh Trading showcases an astonishing gain of 4,657%, while Axis Solution follows closely with 1,081%. Other strong performers are Sterlite Technologies and Cupid, each demonstrating impressive growth. Analysts are hopeful for a market rebound thanks to falling crude oil prices, which could positively impact sectors such as automotive, capital goods, and pharmaceuticals.
Are gilt funds a good bet amid rising interest rates?
As bond yields rise, gilt funds, which invest in government securities, are drawing significant attention from investors seeking low credit-risk options. While these investments benefit from government backing, they still carry inherent risks. The performance of gilt funds hinges on bond price changes prompted by interest rate shifts, sparking discussions among market participants about whether bond yields have peaked.
Tata, HDFC, ICICI Prudential mutual funds halt fresh gold FoF investments: What it means for existing and new investors
Leading mutual fund houses such as Tata Mutual Fund and HDFC Mutual Fund have suspended fresh investments in their gold fund-of-funds. The halt comes as a response to macroeconomic factors affecting gold imports and the value of the rupee. Existing investments in these funds remain unaffected, allowing ongoing systematic plans to continue. New investors now have alternative options for gold exposure, including direct investments in Gold ETFs.
RBI MPC rate hike: Experts decode what the policy decision means for mutual fund investors
The RBI raised the repo rate by 25 basis points to 5.50%, its first hike in nearly four years. Mutual fund managers favour short-duration, high-quality debt, while cautioning investors on duration, inflation, crude prices, global rates and tightening liquidity.
Mid-sized restaurants hungry for funds as investors stay away
Mid-sized organized restaurant chains face financing challenges. Investors are being more cautious, focusing on sustainable profits and unit economics. As a result, several chains explore capital raises or stake sales. Recent investments favor businesses demonstrating strong financial performance and growth potential. Meanwhile, larger investments continue to thrive, creating a divide in the restaurant industry.
- Go To Page 1
Gems, jewellery exporters rush to beat new US tariff deadline
Mumbai and Surat’s gems and jewellery exporters are stepping up production and rushing shipments to the US ahead of a potential new tariff deadline in October. Units in Mumbai’s SEEPZ and Surat’s diamond-cutting hub have extended working hours to clear Christmas and holiday-season orders before October 16, amid uncertainty over possible duties under the Sanctioning Russia and Iran Act.
NFO Alert: Mirae Asset Mutual Fund launches Mirae Asset Life Cycle Fund 2056
Mirae Asset Mutual Fund launched the Life Cycle Fund 2056, an open-ended scheme with a predetermined maturity and mandatory glide path. The NFO closes October 12, with investments starting at Rs 5,000. The fund dynamically shifts allocations from equity toward debt, arbitrage and commodities as the 2056 maturity approaches.
Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman role
Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna, instrumental in Healthium's growth and acquisitions since 2018, will aid in successor selection. Despite record revenue, the medical devices firm saw profits decline recently, facing market competition and a slowdown in the Indian surgical products sector.
Bafna Motors sells 4-acre plot in Navi Mumbai’s Nerul to Greenscape IT Park
Bafna Motors was liable to pay Rs 129 crore to United Bank of India and Rs 15 crore to Tata Motors Finance Solutions. It approached Greenscape IT Park LLP to repay these loans on its behalf. Greenscape IT Park LLP repaid these dues in August and has now acquired the land parcel. The deal attracted stamp duty of Rs 7.27 crore and was registered on August 28, shows the documents accessed through CRE Matrix.
Zepto hires CoinSwitch Kuber’s Ramesh Bafna as CFO
Bafna will replace Jitendra Nagpal - who joined Zepto in September 2021 - by the middle of next month, according to a statement by the firm.
TCR Engineering executing 84 gas pipeline testing projects: President Rohit Bafna
"We are currently undertaking Non-Destructive Test (NDT) and inspection activity on gas infrastructure pipeline projects at over 84 sites across India. Our role includes testing or inspection of the pipelines and giving them certification," the company's global president Rohit Bafna told PTI.
CoinSwitch appoints Ramesh Bafna as CFO
With over 18 years of experience, Bafna has built a sustainable marketplace revenue model in e-commerce companies such as Myntra and Flipkart as well as led the finance workstreams at IT services major Wipro.
Former Myntra CFO Ramesh Bafna frontrunner to be new Zilingo CEO
This comes at a time when the Zilingo's board is thinking about removing cofounder and CEO Ankiti Bose, who is presently suspended from the ecommerce firm.
In talks with multinational pharma cos for acquisition of brands: Bafna pharmaceuticals
The Earnings Before Interest Depreciation and Amortization (EBITDA) for the half year ending September 30, 2021 was at Rs 7.43 crore, as against Rs 4.28 crore registered in the same period of last financial year, the statement added.
A win-win situation: Bafna Motors customers get business opportunities with Cargo Connect
Cargo Connect makes use of its long-standing relationships with large corporates and its substantial marketing strength.
This startup entrepreneur turns lensman over weekend
Prmod Bafna runs an online fashion startup and is open to business collaborators approaching him with assignments.
Strides to pick up 74% stake in Bafna through a special purpose vehicle
Last week, the company invested in US-based research company, Oncobiologics, which is working to bring key biosimilar drugs to the Indian market.
Strides Arcolab to take control of Bafna's India branded generics biz for Rs 48.1 crore
Bafna will continue to manufacture and supply the products from its existing manufacturing facilities for a period of five years.
Bafna Pharmaceuticals proposes to raise funds
Bafna Pharmaceuticals today said it is looking to raise funds from various modes and is also in early stages of negotiations.
Bafna Pharma launches pain management and anti-infective products
Bafna Pharmaceuticals today said it has launched pain management and anti-infective products in the domestic market.
Bafna Pharmaceuticals recommends 6% dividend for 2012-13
The Board of Directors of Bafna Pharmaceuticals at its meeting held on May 20, 2013 have recommended 6% dividend.
Bafna Pharmaceuticals gets nod from Ghana for Omeran-20
Bafna Pharmaceuticals has received approval from Ghana to market Omeran-20 capsules used for the treatment of reflux oesophagitis.
Bafna Pharma Q4 net loss at Rs 2.08 crore
Bafna Pharmaceuticals reported a widening of its standalone net loss to Rs 2.08 crore for the quarter ended March 31, 2012.
Heard on the Street: Bafna jumps 7% on MNC stake buy talk
Shares of Chennai-based Bafna Pharmaceuticals rose 6.8% to `51.75 on Thursday on speculation a multinational drug firm may acquire one of its brands.
Bafna Pharma gets Ghana's approval for hypertension drug
Bafna Pharmaceuticals on Wednesday said it has received Ghana health regulator's approval to sell Atenolol tablets, used in the treatment of hypertension, in the Ghana market.
Bafna Pharma close to sealing UK buy, launch 27 new products
BSE-listed Bafna Pharmaceuticals is close to acquiring a company in the UK having approvals to sell generic drugs, a source close to the development said.
Bafna Pharma gets UK approval for anxiety drug
Bafna Pharmaceuticals today said its manufacturing plant at Chennai has got approval from the UK health regulator to produce clonazepam tablets, used in treating anxiety, to be sold in UK market.
Bafna Pharma bags UK nod for Paracetamol, Loperamide
Bafna Pharmaceuticals on Thursday said it has received approval from the UK health regulator to produce popular drug Paracetamol and Loperamide capsules.
Load More
